Surgical Breast Resection With or Without Axillary Lymph Node Excision in Treating Women With Breast Cancer
- Conditions
- Breast Cancer
- Registration Number
- NCT00210236
- Lead Sponsor
- Institut Bergonié
- Brief Summary
This randomized phase III trial is studying surgery and axillary lymph node dissection to evaluate if systematic axillary node clearance can be avoided in locoregional treatment for operable breast cancer smaller than 10 mm among menopausal women older than 50
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- Female
- Target Recruitment
- 592
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Overall Survival (5 years)
- Secondary Outcome Measures
Name Time Method Axillary recurrence (5 years) Cancer Survival (5 years)
Trial Locations
- Locations (14)
Centre Régional de Luttre Contre le Cancer de Nantes
🇫🇷Saint Herblain, France
Centre Régional de Luttre Contre le Cancer de Dijon
🇫🇷Dijon, France
Centre Hospitalier Universitaire d'Agen
🇫🇷Agen, France
Centre Régional de Luttre Contre le Cancer de Lille
🇫🇷Lille, France
Centre Régional de Lutte Contre le Cancer d'Anger
🇫🇷Angers, France
Centre Régional de Luttre Contre le Cancer de Clermont Ferrand
🇫🇷Clermont Ferrand, France
Centre Hospitalier Intercommunal de Marmande
🇫🇷Marmande, France
Centre Régional de Lutte Contre le Cancer de Lyon
🇫🇷Lyon, France
Centre Régional de Luttre Contre le Cancer de Montpellier
🇫🇷Montpellier, France
Centre Hospitalier Universitaire de Saint Nazaire
🇫🇷Saint Nazaire, France
Centre Régional de Luttre Contre le Cancer de Strasbourg
🇫🇷Strasbourg, France
Clinique de la Source
🇫🇷Orléans, France
Centre Regional de Lutte Contre le Cancer de Toulouse
🇫🇷Toulouse, France
Institut Bergonié - Centre Régional de Luttre Contre le Cancer de Bordeaux et du Sud Ouest
🇫🇷Bordeaux, France